Gender differences in psychoactive substances causing emergency department admissions in children and adolescents
Clinical Toxicology. 2026. Hélène Peyrière, Anne Batisse, Nicolas Malafaye, Isabelle Giraud, Marie-Christine Picot, Erika Nogue
Factors associated with the development of systemic versus local infections in people who inject drugs
Drug and Alcohol Dependence. 2026. Reem Sabra, Hélène Donnadieu, Céline Eiden, Vincent Le Moing, Hélène Peyrière, the French Addictovigilance Network (FAN)
Emerging new psychoactive ketamine analogues: patterns of use and health risks identified by the French Addictovigilance Network
International Journal of Drug Policy. 2026. Salim Mezaache, Liselotte Pochard, Hélène Peyrière, Nathalie Fouilhé Sam-Laï, Joëlle Micallef
Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019-2023)
Fundam Clin Pharmacol. 2026. Zenab Alhamidi, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Céline Eiden, Joëlle Micallef
Overcoming barriers to the prescription/dispensation of take-home naloxone among French primary care professionals: a regional training initiative.
Eur J Public Health. 2026. Aurélie Aquizerate, Mélanie Duval, Morgane Rousselet, Emmanuelle Jaulin, Emmanuelle Kuhn, Anne-Claire Oger, Isabelle Nicolleau, Solen Pele, Thomas Herault, Pascal Artarit, Edouard-Jules Laforgue, Caroline Victorri-Vigneau
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024
Fundam Clin Pharmacol. 2026. Cécile Chevallier, Anne Batisse, Emilie Monzon, Nathalie Richard, Nicolas Authier, Chouki Chenaf, Louise Gaboriau, Véronique Ferey, Basile Chretien, Sophie Fedrizzi, Marine Auffret
[Erosive cystitis associated with chronic ketamine use: A case report]
Therapie. 2026. Louise Bernet, Ahmed Hichem Elnedjar, Célian Bertin
[Erosive cystitis associated with chronic ketamine use: A case report] Lire la suite »
Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023
Psychopharmacol. 2026. Tiphaine Raingeard, Thomas Soeiro, Caroline Victorri-Vigneau, Reynald Le Boisselier, Alexandra Boucher, Nathalie Fouilhé Sam-Laï, Salim Mezaache, Joëlle Micallef
Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents
British Journal of Clinical Pharmacology. 2025. Peyrière H, Batisse A, Fouilhe Sam-Laï N, Daveluy A, Fournier-Choma C, Deheul S, Chevalier C, Lacroix C, Gibaja V, Aquizerate A, Pain S, Jouanjus E, Picot MC, Nogue E
Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis
Heart. 2025. Storck W, Elbaz M, Vindis C, Déguilhem A, Lapeyre-Mestre M, Jouanjus E